NOV 04, 2019 11:44 AM PST

Gene Variant Could Be a Therapeutic Target For Alzheimer Disease

WRITTEN BY: Nouran Amin

A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The individual was a woman who carried a gene mutation prone to the development of early-onset Alzheimer but has not developed the symptoms until 30 years after the expected age of onset. Such observation led researchers on a study funded by the National Institute on Aging (NIA) that highly suggests how a gene variant could be the key to new target therapeutic.

Learn more about Alzheimer disease:

"Sometimes close analysis of a single case can lead to discovery that could have broad implications for the field," said NIA Director Richard J. Hodes, M.D. "We are encouraged that as part of our wide array of studies, this research in the unique genetic makeup of an exceptional individual can reveal helpful information."

In the study, researchers believe that the the woman who carried the gene mutation may have been protected from early Alzheimer symptoms because she also carried two copies of the APOE3 Christchurch (APOE3ch) gene variant. The variant was named after Christchurch, New Zealand were it was first identified.

Early-onset Alzheimer disease is heavily influenced by genetic factors and affects less than 10% of all people who have Alzheimer. The symptoms on average appear between 30 to 60 years of age. Experiments demonstrated in the study sought to address how the APOE3ch variant may reduce the brains ability from forming plaques—a hallmark of the disease.

Findings were published in the paper, “Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report” and shows how APOE3ch variant holds the potential to be a new way of treating or preventing Alzheimer disease.

Source: National Institute on Aging

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 22, 2020
Neuroscience
Psychedelic Experiences Reduce Narcissistic Personality Traits
OCT 22, 2020
Psychedelic Experiences Reduce Narcissistic Personality Traits
Researchers from the UK have found that psychedelic drugs can positively affect narcissistic personality traits- by redu ...
OCT 20, 2020
Drug Discovery & Development
The Power of Extracellular Vesicles
OCT 20, 2020
The Power of Extracellular Vesicles
What are extracellular vesicles (EVs)? They are tiny nanometer sized messengers that transport themselves between cells ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
Loading Comments...